News Author: Sara Freeman Publish date: September 21, 2016
Key clinical point: The risk for pneumonia associated with drugs containing inhaled corticosteroids (ICS) is outweighed by the reduction in chroni...
News Author: Sara Freeman Publish date: September 20, 2016
Key clinical point: Siponimod is an investigational treatment that could help patients with secondary progressive multiple sclerosis.
Major findin...
News Author: Sara Freeman Publish date: September 19, 2016
News Author: Sara Freeman Publish date: September 19, 2016
Key clinical point: Maintenance azithromycin may be best reserved for patients with more mild to moderate chronic obstructive pulmonary disease an...
News Author: Sara Freeman Publish date: September 16, 2016
Key clinical point: Benralizumab significantly reduced the annual exacerbation rate (AER), improved lung function, and reduced asthma symptoms. Maj...
News Author: Sara Freeman Publish date: September 16, 2016
Key clinical point: RPL-554 added to short-acting reliever medications produced greater lung function benefits than did the monotherapies.
Major f...
News Author: Sara Freeman Publish date: September 15, 2016
Key clinical point: Using home mechanical ventilation (HMV) plus home oxygen therapy (HOT) significantly improves the length of time patients stay ...
News Author: Sara Freeman Publish date: September 15, 2016
Key clinical point: A triple, fixed-dose combination therapy delivered by a single inhaler could be a new treatment option for severe COPD.
Major ...
News Author: Sara Freeman Publish date: September 10, 2016
Key clinical point: Step-down treatment works well in routine asthma care, with no loss of control or lung function decline.
Major finding: No sig...
News Author: Sara Freeman Publish date: July 7, 2016
Key clinical point: Biosimilar etanercept (CHS-0214) was shown to be as effective and well tolerated as etanercept.
Major finding: ACR 20 at 24 we...
News Author: Sara Freeman Publish date: July 7, 2016
Key clinical point: Two new oral Janus kinase inhibitors selective for JAK-1 have shown promising efficacy and safety in separate phase II trials....
News Author: Sara Freeman Publish date: July 6, 2016
News Author: Sara Freeman Publish date: July 5, 2016
Key clinical point: Several eye abnormalities can be mistaken for hydroxychloroquine-related eye toxicity, making specialist ophthalmic assessment...
News Author: Sara Freeman Publish date: June 27, 2016
The interleukin-6 inhibitor tocilizumab (Actemra) substantially reduced skin thickening in patients with systemic sclerosis in the “proof-of concept” ...
Article Author: Sara Freeman Publish date: June 27, 2016
Topics include: TNF inhibitors & IBD in pregnancy • Vision loss in giant cell arteritis • Pediatric mental illness: diagnosis & p...
